Cargando…
RGS11-CaMKII complex mediated redox control attenuates chemotherapy-induced cardiac fibrosis
Dose limiting cardiotoxicity remains a major limiting factor in the clinical use of several cancer chemotherapeutics including anthracyclines and the antimetabolite 5-fluorouracil (5-FU). Prior work has demonstrated that chemotherapeutics increase expression of R7 family regulator of G protein signa...
Autores principales: | Das, Kiran, Basak, Madhuri, Mahata, Tarun, Kumar, Manish, Kumar, Dinesh, Biswas, Sayan, Chatterjee, Suvro, Moniruzzaman, Mahammed, Saha, Nimai Chandra, Mondal, Kausik, Kumar, Pranesh, Das, Priyadip, Stewart, Adele, Maity, Biswanath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557029/ https://www.ncbi.nlm.nih.gov/pubmed/36228439 http://dx.doi.org/10.1016/j.redox.2022.102487 |
Ejemplares similares
-
A RGS7-CaMKII complex drives myocyte-intrinsic and myocyte-extrinsic mechanisms of chemotherapy-induced cardiotoxicity
por: Basak, Madhuri, et al.
Publicado: (2022) -
Hepatic Regulator of G Protein Signaling 6 (RGS6) drives non-alcoholic fatty liver disease by promoting oxidative stress and ATM-dependent cell death
por: Mahata, Tarun, et al.
Publicado: (2021) -
Self-assembled dipeptide based fluorescent nanoparticles as a platform for developing cellular imaging probes and targeted drug delivery chaperones
por: Sivagnanam, Subramaniyam, et al.
Publicado: (2022) -
G protein β5-ATM complexes drive acetaminophen-induced hepatotoxicity
por: Pramanick, Arnab, et al.
Publicado: (2021) -
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012)